Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein.
about
Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts.Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing AntibodiesFunctional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individualsMonoclonal antibodies to the V2 domain of MN-rgp120: fine mapping of epitopes and inhibition of α4β7 bindingNeutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates.Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers.Antigenic variation within the CD4 binding site of human immunodeficiency virus type 1 gp120: effects on chemokine receptor utilization.Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.Sequence-conserved and antibody-accessible sites in the V1V2 domain of HIV-1 gp120 envelope protein.Type-specific epitopes targeted by monoclonal antibodies with exceptionally potent neutralizing activities for selected strains of human immunodeficiency virus type 1 map to a common region of the V2 domain of gp120 and differ only at single positioEpitope mapping of conformational V2-specific anti-HIV human monoclonal antibodies reveals an immunodominant site in V2.Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop.Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein.Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein.Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoproteinAntibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate.Distinct mechanisms regulate exposure of neutralizing epitopes in the V2 and V3 loops of HIV-1 envelope.Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1.Development of a neutralizing antibody response during acute primary human immunodeficiency virus type 1 infection and the emergence of antigenic variants.Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope proteinLocation, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoproteinLength polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site.Identification of novel structural determinants in MW965 Env that regulate the neutralization phenotype and conformational masking potential of primary HIV-1 isolates.
P2860
Q22010245-18DA361C-FBB4-4063-81EA-0BC993460EC5Q27469663-8C6E0911-A073-4783-AB6A-DF77A7199D3DQ27487399-229AE97B-74FD-4318-A25E-C38CB38276B5Q27677941-81AD34AB-8C03-4652-B8D0-A1AB9BD71C96Q28728517-096938D3-A4F9-4836-9CB7-C065594889B1Q33782556-4C7CF416-2301-4004-B7BD-E1BBB32B3E6EQ33788792-028A4411-661B-4D83-935F-D4904E48AE9BQ33836042-2047D6FD-BE5C-4B35-AF34-6FB225C2B16DQ33841969-950A27E3-2312-4E5F-89AE-0AEB3CBB4116Q33842152-949D380A-2517-4D55-AA23-C662451A5A27Q34116932-6C3EBAC9-64B7-4E1B-899A-FD33499BCB10Q34583767-96273AC5-B222-4E48-A3C3-A210EBC229DBQ34907398-8164866C-37DF-4A27-85FE-A29BC1ADFAA4Q35651494-9E1E94B4-2909-46F0-B53A-98E5E02E79C5Q35845976-468E6624-12B7-46F0-9CB9-D2024B977D8EQ35857331-09C6300A-37C2-401C-98AD-85A18A77A8BCQ35857404-852DD98F-C1E5-418C-BCFA-C4543D98838DQ36366296-70ED67AB-8398-4AD9-B531-0E43BD2CE21EQ36549220-AF625B35-8C0B-4627-9096-36991A2227F6Q36549382-1AF9AB04-597A-4035-80CF-07C7A67B41C4Q36565346-4062B820-DE44-4789-BA91-599FF44AD3A8Q38962226-DDFB9FBC-297E-494B-B973-73BC4A5424D3Q39193318-FECA1D12-E95F-42CA-B03B-DE6025ACF011Q39582046-C20C5B7E-F066-4953-AFDE-550C70DEEFE4Q39592994-C9590DAB-CC79-4E93-BBE3-DAC0138D3DA9Q39875204-E0338196-8CCA-475A-874A-8E4DC0A4638BQ39877884-845B4E98-AAAC-4D58-9701-67DBFD3E0D48Q47566053-7CCB4BE4-9652-48A2-A86D-75F78DA5671B
P2860
Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Identification and characteriz ...... type 1 envelope glycoprotein.
@ast
Identification and characteriz ...... type 1 envelope glycoprotein.
@en
type
label
Identification and characteriz ...... type 1 envelope glycoprotein.
@ast
Identification and characteriz ...... type 1 envelope glycoprotein.
@en
prefLabel
Identification and characteriz ...... type 1 envelope glycoprotein.
@ast
Identification and characteriz ...... type 1 envelope glycoprotein.
@en
P2093
P2860
P1433
P1476
Identification and characteriz ...... s type 1 envelope glycoprotein
@en
P2093
J A McKeating
J Sodroski
Q Sattentau
P2860
P304
P407
P577
1995-01-01T00:00:00Z